Meet Our Speakers

The COVID Advocacy Exchange has engaged close to 100 global and local advocacy organizations, spanning disease states, to convene virtually in their common pursuit of supporting patients with serious diseases who are simultaneously navigating the current COVID-19 pandemic. The virtual platform provides access to data and information, as well as the opportunity to participate in live, interactive sessions to foster discussion and collaboration.

Click on speaker name to see bio

Speakers for November 12th: Taking Action to Correct Health Inequities

John L. Damonti

Bristol-Myers Squibb Foundation

Speakers for October 14th: Moving Forward and Rebuilding

Adam Grant

Organizational Psychologist
The Wharton School of Business
Bestselling Author
Host: WorkLife, a TED Original Podcast

Chris Boerner, PhD

Executive Vice President
Chief Commercialization Officer
Bristol Myers Squibb

Speakers for October 8th: Getting Back to Work

Tinamarie Duff

Global Lead
BMS’s DAWN (Differently-Abled Workplace Network) People and Business Resource Group
Bristol-Myers Squibb

Noreen Gleason

Executive Director
Business Continuity and Corporate Event Response Team Lead
Bristol-Myers Squibb

Speakers for September 10th: Getting Back to Normal: Care, Work and Support for All – Inspired by You

Dr. Nicholas A.J. Botwood

BSc, MB BS, MRCP, MFPM, Head of US Medical Affairs, Interim Head of Oncology Development, Bristol Myers Squibb

Speakers for July 23rd: The Patient Voice & Patient-Focused Drug Development

Oriana Sousa

SCOCHT survivor, Founder/Psychologist, Dealing with Cancer, Patient Advocate, Rare 2030, EUPATI Student

Tamás Bereczky

MA, PhD, Courses and Contents Coordinator, EUPATI

Kathleen A. Arntsen

President & CEO, Lupus and Allied Diseases Association, Inc.

Begonya Nafria

Coordinator, Share4Rare & Patient Engagement in Research Coordinator, Sant Joan de Déu Children's Hospital

Danielle Halstrom

Head, R&D, GPS and Commercial Communications & Global Advocacy Corporate Affairs, Bristol Myers Squibb

Samit Hirawat

M.D., Chief Medical Officer, Global Drug Development, Bristol Myers Squibb

Speakers for July 16th: Reshaping Healthcare: Thinking Differently after COVID

Ester Banque

SVP & Head of Intercontinental Commercial, Bristol-Myers Squibb

Eleanor M. Perfetto Edwards

Ph.D., M.S., Executive Vice President, Strategic Initiatives, National Health Council (NHC)

Lily Cannon

Operations Manager, Thalassaemia International Federation (TIF)

KT Jones

Cancer Survivor & Patient Advocate

Katie Rizvi

Youth Cancer Europe Co-Founder and Executive Director

Speakers for July 9th: Preventive Care & COVID

Anita Wiseman

Campaigns and Partnerships, World Stroke Organization

Lisa Berry Edwards

Managing Director, External Affairs, Prevent Cancer Foundation

Richard Wender

M.D., Professor, Family and Community Medicine, Thomas Jefferson University

Jessica Valence

Colorectal Cancer Survivor, Patient Advocate, Director of Operations, GRYT Health

Robert C. Block

MD, MPH, FACP, FNLA, Associate Professor, Department of Public Health Sciences and the Cardiology Division, Department of Medicine, University of Rochester

Patrick E. McBride

MD, MPH, FAHA, FACC, FNLA, Emeritus Professor of Medicine and Family Medicine, University of Wisconsin School of Medicine and Public Health; Former Associate Dean of Faculty, and Associate Dean for Students; Former Director, UW Preventive Cardiology Program

Speakers for July 2nd: Practical Solutions for Patients during COVID

Gaetano Crupi

President and General Manager, Bristol-Myers Squibb Brazil

Kelly Brassil

Ph.D., R.N., Director of Medical Affairs, Pack Health

Megan-Claire Chase

Cancer Survivor, Blogger & Patient Advocate

Pat Masterson

Vice President, HUSCO International, MaskForce LLC

Anders Thelborg

General Manager, Bristol Myers Squibb Denmark

Diane Gross

National Director of Advocacy and Programs, Lupus Research Alliance

Speakers for June 25th: Mental Health, Well-Being, and Psychosocial Support for Patients

Jasmin Watson-El

MS Patient Ambassador

Catherine Benedict

Ph.D., Psychologist, Stanford University School of Medicine

Dominika Czarnota-Szałkowska

Secretary General, Polish Multiple Sclerosis Society, Executive Committee Member, European Multiple Sclerosis Platform

Teri S. Brister

Ph.D., LPC, National Director Research & Quality Assurance, National Alliance on Mental Illness (NAMI)

Kelly Davis

Director of Peer Advocacy, Supports, and Services, Mental Health America (MHA)

Speakers for June 18th: Telemedicine and Access to Care

Adriana Zupa-Fernandez

Global PBRG (People & Business Resource Group) Lead, Bristol Myers Squibb

Sandeep Pulim M.D.

Chief Medical Officer, Bluestream Health

Dr. Morhaf Al Achkar

Lung Cancer survivor, Family Physician UW Medicine

Matt Bouchonville

MD, Associate Professor, Division of Endocrinology, Associate Director, ECHO Institute, University of New Mexico School of Medicine

Leticia Ferri

MD MSc MBA PhD, Global Lead, OLA (Organization for Latino Achievement), Bristol Myers Squibb

Sirisha Mohan M.D.

Clinical Assistant Professor, Telemedicine Physician Lead, Interim Associate Program Director, Family Medicine Residency Program, Department of Family Medicine, Keck School of Medicine

Speakers for June 11th: Safely Returning to Clinical Trials

Kathryn (Kate) Owen

Sr. Vice President, Global Development Operations, Bristol Myers Squibb

Kathleen Griffin

Executive Director, Partnerships and Digital Engagement, Syneos Health

Dr. Amy C. Moore

Director, Science & Research, GO2 Foundation for Lung Cancer</span >

Upal Basu Roy, PhD,MPH

Vice President of Research, LUNGevity Foundation

Christopher D. Ferris, MD, PhD,MPH

Gastroenterologist, Tryon Medical Partners

Speakers for June 4th: Going Virtual--Best Practices for Advocacy Organizations

Dave Fuehrer

CEO, and CoFounder, GRYT Health

Shwen Gwee

VP and Head of Global Digital Strategy, BMS

Lorna Warwick

CEO, Lymphoma Coalition

Nick Giallourakis

Co-Founder and President, Elephants and Tea

Crista Lopes

Professor, University of California, Irvine

Speakers for May 28th: Coalitions & Collaboration

Pat Garcia-Gonzalez

CEO, The Max Foundation

Dr. Cary Adams

CEO, Union for International Cancer Control (UICC)

Trudie C A Lobban

MBE, Founder & Trustee, Arrhythmia Alliance, Founder & CEO, AF Association, Founder & CEO, STARS

Speakers for May 21st: Welcome & Intro

Cathy Trzaskawka

Executive Director & Head, Global Advocacy, Bristol-Myers Squibb

Catherine Owen

Senior Vice President, Major Markets, Bristol-Myers Squibb

Wayne Eskridge

CEO, Fatty Liver Foundation

Seth D. Ginsberg

CO-Founder, Global Healthy Living Foundation (GHLF)

Andrea Vassalotti

Partnerships & Programmes Director, World Heart Federation

Gary Nolan

Managing Director, Scientific Education Support (SES)